ArticleJournal of ophthalmology2026
One-Year Outcomes of Topography-Guided LASIK for Myopia and Astigmatism.
Article in Journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- One-Year Outcomes of Topography-Guided LASIK for Myopia and Astigmatism.Journal of ophthalmology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: To assess the efficacy and safety of topography-guided LASIK (TG-LASIK) in correcting myopia and astigmatism and to evaluate clinical outcomes and visual quality postoperatively. Methods: We conducted a prospective study including patients aged 18-40 years with stable refraction for over 12 months. The outcomes measured were uncorrected distance visual acuity (UDVA), contrast sensitivity, higher-order aberrations (HOAs), and patient-reported visual quality using a validated Quality of Vision (QoV) questionnaire. Results: A total of 86 eyes of 43 patients were analyzed. At 12 months postoperatively, 97% of the eyes achieved a UDVA of 20/20 or better, and 99% maintained or improved their corrected distance visual acuity (CDVA). The mean UDVA remained stable over time ( Conclusions: TG-LASIK is an effective approach in personalized refractive surgery, demonstrating safety and efficacy in improving visual quality for myopia and astigmatism. The improvement in visual quality, despite an increase in HOAs, suggests the effectiveness of personalized ablation profiles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.